BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1153355)

  • 1. The study of the bioavailability of coated acetylsalicylic acid in suppositories after rectal administration.
    Stozek T
    Pol J Pharmacol Pharm; 1975; 27(2):227-33. PubMed ID: 1153355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The bioavailability of combination preparations of acetylsalicylic acid and codeine phosphate].
    Spahn H; Altmayer P; Cattarius-Korb S; Krüger B; Lang E; Mutschler E; Sörgel F
    Arzneimittelforschung; 1985; 35(6):973-6. PubMed ID: 4026924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of particle size on rectal absorption of aspirin.
    Parrott EL
    J Pharm Sci; 1975 May; 64(5):875-80. PubMed ID: 1151665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability and tolerance studies on acetylsalicylic acid suppositories.
    Borg KO; Ekenved G; Elofsson R; Sjögren J; Sölvell L
    Acta Pharm Suec; 1975; 12(5-6):491-8. PubMed ID: 1217502
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative studies on the in vitro dissolution and bioavailability of various acetylsalicylic acid preparations].
    Nieder M; Rasper J; Gielsdorf W; Russmann D; Jaeger H
    Arzneimittelforschung; 1983; 33(3):439-45. PubMed ID: 6683520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bioavailability of morphine in controlled-release 30-mg tablets per rectum compared with immediate-release 30-mg rectal suppositories and controlled-release 30-mg oral tablets.
    Kaiko RF; Fitzmartin RD; Thomas GB; Goldenheim PD
    Pharmacotherapy; 1992; 12(2):107-13. PubMed ID: 1570227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of aspirin after oral and rectal administration in volunteers and patients with fever.
    Dalvi SS; Gupta KC; Pohujani SM; Vaidya AB; Satoskar RS
    J Postgrad Med; 1985 Oct; 31(4):192-5. PubMed ID: 3834082
    [No Abstract]   [Full Text] [Related]  

  • 8. The bioavailability of enteric-coated acetylsalicylic acid: a comparison with buffered ASA in rheumatoid arthritis II.
    Canada AT; Little AH; Creighton EL
    Curr Ther Res Clin Exp; 1976 May; 19(5):554-7. PubMed ID: 820521
    [No Abstract]   [Full Text] [Related]  

  • 9. Rectal absorption from aspirin suppositories in children and adults.
    Nowak MM; Brundhofer B; Gibaldi M
    Pediatrics; 1974 Jul; 54(1):23-6. PubMed ID: 4834297
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Absolute bioavailability of a special sustained-release acetylsalicylic acid formulation].
    Lücker PW; Swoboda M; Wetzelsberger N
    Arzneimittelforschung; 1989 Mar; 39(3):391-4. PubMed ID: 2757664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose evaluation of a new enteric-coated aspirin preparation.
    Paull P; Day R; Graham G; Champion D
    Med J Aust; 1976 Apr; 1(17):617-9. PubMed ID: 933973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biopharmaceutical investigation of rectal suppositories. Part 2(1): Pharmaceutical and biological availability of phenobarbital and phenobarbital-sodium.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1985 Apr; 40(4):257-9. PubMed ID: 3839310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of ethanol on the in vitro and in vivo drug release from some sustained release tablets (author's transl)].
    Frömming KH; Topaloglu Y
    Arzneimittelforschung; 1975; 25(12):1958-64. PubMed ID: 3188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of certain active principles and excipients on the biodisposition of rectally administered acetylsalicylic acid in the rabbit].
    Fehri B; Aiache JM; Boukef K
    J Pharm Belg; 1989; 44(3):197-209. PubMed ID: 2795423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of aspirin from commercial suppositories.
    Gibaldi M; Grundhofer B
    J Pharm Sci; 1975 Jun; 64(6):1064-6. PubMed ID: 1133735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The biologic availability of acetylsalicylic acid suppositories].
    Süss W; Martin A
    Pharmazie; 1986 Nov; 41(11):817-8. PubMed ID: 3562519
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative bioavailability of sustained-release and uncoated aspirin tablets.
    Karahalios WJ; Sawyer WT; Rittase RA; Maynard SA
    Am J Hosp Pharm; 1981 Nov; 38(11):1754-6. PubMed ID: 7304632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the bioavailability of aspirin tablets and suppositories.
    Superstine SY; Superstine E; Penchas S
    Isr J Med Sci; 1978 Feb; 14(2):292-4. PubMed ID: 649361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.